Skip to main content
logo
APT Neuroscience, Inc. (KOSDAQ:270520)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,286.00
-6.00 (-0.46%)
Aug 8, 2025, 3:30 PM KST
-0.46%
Market Cap250.11B
Revenue (ttm)20.08B
Net Income (ttm)-8.45B
Shares Out193.58M
EPS (ttm)-54.83
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume396,002
Average Volume1,461,109
Open1,291.00
Previous Close1,292.00
Day's Range1,275.00 - 1,304.00
52-Week Range944.00 - 2,085.00
Beta1.90
RSI44.41
Earnings DateAug 14, 2025

About Verve Therapeutics

APT Neuroscience, Inc. provides hydrothermal and geothermal heating and cooling systems in South Korea. It also engages in the mechanical and electrical construction activities, and provision of fuel cells for buildings and power generation. The company serves residential customers and public institutions. The company was formerly known as Geolit Energy Co.,Ltd. and changed its name to APT Neuroscience, Inc. in February 2025. APT Neuroscience, Inc. was founded in 2002 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Air-Conditioning and Warm Air Heating Equipment and Commercial and Industrial Refrigeration Equipment
Founded 2002
Employees 54
Stock Exchange KOSDAQ
Ticker Symbol 270520
Full Company Profile

Financial Performance

In 2024, APT Neuroscience's revenue was 18.38 billion, a decrease of -9.98% compared to the previous year's 20.42 billion. Losses were -19.17 billion, 283.1% more than in 2023.

Financial Statements

News

There is no news available yet.